LATEST ALERTS
Health and science
Italy’s top court rules that oral CBD products are prescription drugs
30th April 2025 - News analysis |
Italy’s Regional Administrative Court (TAR) has dismissed an appeal challenging the Ministry of Health’s decree to classify oral CBD products as narcotics
Could an AI-driven technique mean more female cannabis plants with less hassle?
24th April 2025 - Blogs , News analysis |
A not-so-new tech enabling growers to sort seeds before planting could be a major cost cutter in an industry built on fine margins and continually having to compete with cheaper, untaxed black market products
Regulatory tracker: current global regulation of CBD, March
27th March 2025 - Regulatory databases |
The CBD regulatory tracker offers a deep analysis of the regulations and proposals in over 50 countries, for nine major regulatory areas: hemp cultivation, processing, flower, extracts, food, cosmetics, vaping, pet food and import/export
United Nations commission votes to classify HHC as a prohibited substance
25th March 2025 - News analysis |
The United Nations Commission on Narcotic Drugs voted on 12th March to classify HHC as a banned substance, with an aim of restricting and controlling the use of the cannabinoid at an international level
A look at the latest academic studies on cannabinoids and cannabis compounds
28th February 2025 - News analysis |
Knowledge about cannabinoids and other cannabis compounds continues to inch forward, but though most recent major reported studies have been positive, that has not universally been the case
Tamarind Intelligence podcast: what’s next for e-cigarette regulation?
24th February 2025 - Podcasts |
Barnaby Page, host of Tamarind Intelligence podcast, sits down with Michael Landl, director of the World Vapers’ Alliance, to unpack the major regulatory hurdles facing the e-cigarette sector in 2025 and beyond
Tamarind Intelligence podcast: Global insights into novel nicotine regulation
14th February 2025 - Podcasts |
Join our host Barnaby Page as he sits down with Pablo Cano Trilla, regulatory director at Tamarind Intelligence, to explore the latest global updates on novel nicotine regulation.
Embrapa to launch cannabis cultivation research programme…
13th February 2025 - Alerts | Brazil, South America |
Do US cannabis companies need to resort to drastic measures to stay in business?
31st January 2025 - Blogs , News analysis |
Cannabis companies have been pushing the envelope of acceptable marketing and business practices by insinuating unproven benefits for their products while also looking to create the strongest goods possible
Luxembourg to halt high-THC cannabis flower prescriptions by January 2025
30th December 2024 - News analysis |
As of 1st January 2025, eligible patients in Luxembourg will no longer be able to receive prescriptions for dried cannabis flower with a high THC content
Tamarind Intelligence podcast: 2024 highlights and 2025 predictions
19th December 2024 - Podcasts |
Join the Tamarind Intelligence leadership team for a compelling round-table discussion with four top industry experts. They’ll reflect on the major moments of 2024 in the reduced-risk nicotine world and share their insights for 2025.
Bern recreational cannabis project extended…
13th December 2024 - Alerts | Europe, Switzerland |
Australian study finds objective scientific evidence that cannabis increases sleep
21st November 2024 - News analysis |
Cannabis may help sleep, according to Australian researchers who found evidence of the hypnotic properties of cannabinol (CBN) and say their study is the first to use objective measures to prove CBN increases sleep
Up to 0.3% THC in plants authorised for medical, pharmaceutical, industrial use…
14th November 2024 - Alerts | Brazil, South America |
Bills introduced in Senate and House on medical cannabis expansion…
14th November 2024 - Alerts | North America, Texas, United States |
Tamarind Intelligence podcast: Impact of novel nicotine products on public tobacco firms
13th November 2024 - Podcasts |
Rupert Wilson, managing director at Strategic Business Consulting and former Rothmans International tobacco expert, sits down with Tamarind Intelligence’s Tim Phillips to examine the influence of novel nicotine products on the performance and strategic direction of public tobacco firms.
Greentank teams up with AIR to develop new line of cannabis-free wellness vapes
7th November 2024 - News analysis |
Canada-based vaping hardware maker Greentank has launched a partnership with Dubai-headquartered group AIR Global, as the shisha market specialist aims to enter the global wellness sector
Tamarind Intelligence podcast: A look into the illicit vape market
16th October 2024 - Podcasts |
Join Tamarind Intelligence founder Tim Phillips and Editorial Director Barnaby Page as they explore the complexities of the illicit e-cigarette trade.
Brazilian pharmaceutical company acquires Colombian cannabis giant
30th September 2024 - News analysis |
Brazilian pharmaceutical company Ease Labs officially announced the acquisition this month of Plena, a cannabis cultivation and extraction company based in Colombia
Could the Czech government be out of step with its own anti-addiction plan?
5th September 2024 - Blogs , News analysis |
Just over a year after the Czech government unveiled a new, ambitious action plan to fight addictions, doubts are being raised over the government’s alignment with its own declared war on addictions
Epidiolex misses trial’s efficacy goal in Japan as it aims for drug authorisation
28th August 2024 - News analysis |
Clinical trials on CBD-based medical drug Epidiolex missed their main goal of registering a significant reduction in the frequency of seizures experienced by patients in Japan, based on the results reported by manufacturer Jazz Pharmaceuticals
Increase in prescriptions of unlicensed medical cannabis sparks concern in UK
26th August 2024 - News analysis |
Unlicensed medical cannabis prescriptions in the UK private medical sector have increased by nearly 120% between 2022 and 2023, raising concerns in the healthcare industry over prescribers’ practices
Chief research officer shares equation for success in developing next-gen products
23rd August 2024 - News analysis |
Businesses that lead product innovation with what the consumer wants will be one step ahead when it comes to taking a next-generation product to market – particularly when making PMTAs in the US
Health Canada looks into non-prescription cannabis health products…
2nd August 2024 - Alerts | Canada, North America |
Enforcement laws on intoxicating hemp products unlikely this year…
13th June 2024 - Alerts | Massachusetts, North America, United States |
Australians use medical cannabis to treat pain, mental issues, survey results show
11th June 2024 - News analysis |
Nearly eight years after the legalisation of medical cannabis in Australia, most people who use it to treat a health condition obtain it legally, through a doctor’s prescription
Health ministry seeks medical cannabis supplier amid shortage…
6th June 2024 - Alerts | Europe, Luxembourg |
Health Canada recalls products with ‘presumed presence’ of HHC…
6th June 2024 - Alerts | Canada, North America |
Contamination and adulteration of vape products: how serious is the problem?
27th May 2024 - News analysis |
The recent discovery of the illicit animal tranquilliser xylazine in cannabis vapes raises concerns about harmful contaminants. How do these substances end up in vaping products?
‘Embarrassing’ lack of progress on medical cannabis bill…
3rd May 2024 - Alerts | North America, United States |
